M. Baru

发表

Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial

H. Mandel, P. Sedgwick, S. Rahman, 2019, Journal of clinical medicine.

Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes

L. Carmel-Goren, M. Baru, R. Yatuv, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C)

M. Baru, R. Yatuv, I. Dayan, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

M. Baru, R. Yatuv, M. Robinson, 2010, International journal of nanomedicine.

Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF

M. Baru, R. Yatuv, I. Dayan, 2010, Expert opinion on drug delivery.

Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy

Yechezkel Barenholz, Y. Barenholz, J. Spira, 2005, Thrombosis and Haemostasis.

Safety and efficacy of a long‐acting liposomal formulation of plasma‐derived factor VIII in haemophilia A patients

J. Spira, N. Zozulya, V. Zorenko, 2012, British journal of haematology.

Enhancement of haemostatic efficacy of plasma‐derived FVIII by formulation with PEGylated liposomes

M. Baru, I. Dayan, M. Robinson, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study

J. Spira, N. Zozulya, O. Plyushch, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Binding of proteins to PEGylated liposomes and improvement of G-CSF efficacy in mobilization of hematopoietic stem cells.

L. Carmel-Goren, M. Baru, R. Yatuv, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.

A. Sigal, Y. Barenholz, M. Harel, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice.

J. H. Axelrod, M. Baru, I. Nur, 1995, Gene.

Retroviral-mediated in vivo gene transfer into muscle cells and synthesis of human factor IX in mice.

M. Baru, I. Nur, J. Sha’anani, 1995, Intervirology.

Lysosome-disrupting peptide increases the efficiency of in-vivo gene transfer by liposome-encapsulated DNA.

O. Nahum, M. Baru, I. Nur, 1998, Journal of drug targeting.

In Vivo Liver-Directed Gene Transfer in Rats and Pigs with Large Anionic Multilamellar Liposomes: Routes of Administration and Effects of Surgical Manipulations on Transfection Efficiency

P. Gianello, M. Baru, M. Otsuka, 2000, Journal of drug targeting.